TrialMultiple sclerosis (Houndmills, Basingstoke, England)2017

High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.

Karen Schreiber et al.PubMed ↗Publisher ↗

No numbers read from the abstract.